Pelthos Therapeutics PTHS
NYSE PTHS
$20.66 -0.35 (-1.67%)
As of: Oct 1, 2026 · 3:53 PM EDT

Pelthos Therapeutics (PTHS) Gross Profit (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) posted Gross Profit of $11.99 million for Q2 2026, up 29.9% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Gross Profit (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Pelthos Therapeutics was $34.03 million; for FY2025, it came in at $12.81 million.

  • According to Business Quant data, Gross Profit for the three prior quarters was $9.23 million (Q1 2026), $7.72 million (Q4 2025) and $5.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.99 Mn
Mar 31, 2026 9.23 Mn
Dec 31, 2025 7.72 Mn
Sep 30, 2025 5.09 Mn
API Access

Pelthos Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=PTHS&period=max&api_key=YOUR_API_KEY